Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Neuropace Inc
(NQ:
NPCE
)
7.920
+0.910 (+12.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
63,652
Open
7.110
Bid (Size)
7.220 (1)
Ask (Size)
8.460 (1)
Prev. Close
7.010
Today's Range
7.005 - 7.960
52wk Range
4.790 - 18.15
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
Performance
YTD
-19.02%
-19.02%
1 Month
-1.86%
-1.86%
3 Month
+5.18%
+5.18%
6 Month
-53.47%
-53.47%
1 Year
+53.49%
+53.49%
More News
Read More
NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
April 17, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings For NeuroPace
March 12, 2024
Via
Benzinga
Recap: NeuroPace Q4 Earnings
March 05, 2024
Via
Benzinga
Earnings Preview: NeuroPace
March 04, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
February 22, 2024
Via
Benzinga
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
January 30, 2024
Via
Benzinga
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
March 05, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
March 05, 2024
Via
InvestorPlace
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Expert Ratings for NeuroPace
December 04, 2023
Via
Benzinga
Expert Ratings for NeuroPace
November 10, 2023
Via
Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Via
Benzinga
Breaking Down NeuroPace: 6 Analysts Share Their Views
December 27, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 06, 2023
Via
Benzinga
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.